GR3031029T3 - Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase. - Google Patents
Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase.Info
- Publication number
- GR3031029T3 GR3031029T3 GR990402107T GR990402107T GR3031029T3 GR 3031029 T3 GR3031029 T3 GR 3031029T3 GR 990402107 T GR990402107 T GR 990402107T GR 990402107 T GR990402107 T GR 990402107T GR 3031029 T3 GR3031029 T3 GR 3031029T3
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- formula
- pharmaceutically acceptable
- pharmaceutically active
- oxazolidine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919124513A GB9124513D0 (en) | 1991-11-19 | 1991-11-19 | Novel process |
| PCT/GB1992/002140 WO1993010254A1 (en) | 1991-11-19 | 1992-11-19 | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3031029T3 true GR3031029T3 (en) | 1999-12-31 |
Family
ID=10704843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990402107T GR3031029T3 (en) | 1991-11-19 | 1999-08-18 | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5726055A (el) |
| EP (2) | EP0905255A3 (el) |
| JP (1) | JP3782099B2 (el) |
| KR (2) | KR100270133B1 (el) |
| AT (1) | ATE181114T1 (el) |
| AU (3) | AU673145B2 (el) |
| CA (1) | CA2123782A1 (el) |
| DE (1) | DE69229402T2 (el) |
| DK (1) | DK0615549T3 (el) |
| ES (1) | ES2132135T3 (el) |
| GB (1) | GB9124513D0 (el) |
| GR (1) | GR3031029T3 (el) |
| HK (1) | HK1012423A1 (el) |
| MX (1) | MX9206679A (el) |
| NZ (1) | NZ245182A (el) |
| PT (1) | PT101077B (el) |
| TW (1) | TW240249B (el) |
| WO (1) | WO1993010254A1 (el) |
| ZA (1) | ZA928937B (el) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| US7091359B2 (en) | 1997-11-04 | 2006-08-15 | Smithkline Beecham Plc | Process for the preparation of thiazolidinedione derivatives |
| GB9723295D0 (en) | 1997-11-04 | 1998-01-07 | Smithkline Beecham Plc | Novel process |
| CA2311125C (en) | 1997-11-19 | 2011-01-18 | Takeda Chemical Industries, Ltd. | Apoptosis inhibitor |
| GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB9726563D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| NZ515168A (en) | 1999-04-23 | 2004-02-27 | Smithkline Beecham Plc | Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt |
| AU765498B2 (en) | 1999-04-23 | 2003-09-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| HU225919B1 (en) * | 1999-12-18 | 2007-12-28 | Richter Gedeon Nyrt | Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates |
| GB0006133D0 (en) * | 2000-03-14 | 2000-05-03 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021865D0 (en) * | 2000-09-06 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0023971D0 (en) * | 2000-09-29 | 2000-11-15 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0023970D0 (en) * | 2000-09-29 | 2000-11-15 | Smithkline Beecham Plc | Novel pharmaceutical |
| EP1291436A1 (en) * | 2001-09-11 | 2003-03-12 | Bayer Ag | Process for the stereoselective preparation of functionalized vicinal diols |
| CZ297347B6 (cs) * | 2004-09-21 | 2006-11-15 | Zentiva, A. S. | Zpusob prípravy rosiglitazonu |
| WO2012153312A1 (en) | 2011-05-11 | 2012-11-15 | Ranbaxy Laboratories Limited | Process for the purification of pioglitazone |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| DE3001303A1 (de) * | 1980-01-16 | 1981-07-23 | Basf Ag, 6700 Ludwigshafen | Optisch aktive phenylpropan-derivate, ihre herstellung und verwendung |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
| US4857468A (en) * | 1985-04-13 | 1989-08-15 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for preparing optically active 2-halo-1-phenyl ethanol |
| US5232925A (en) * | 1987-09-04 | 1993-08-03 | Beecham Group P.L.C. | Compounds |
| SG59988A1 (en) * | 1987-09-04 | 1999-02-22 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
-
1991
- 1991-11-19 GB GB919124513A patent/GB9124513D0/en active Pending
-
1992
- 1992-11-19 CA CA002123782A patent/CA2123782A1/en not_active Abandoned
- 1992-11-19 EP EP98203431A patent/EP0905255A3/en not_active Withdrawn
- 1992-11-19 EP EP92923876A patent/EP0615549B1/en not_active Expired - Lifetime
- 1992-11-19 JP JP50910893A patent/JP3782099B2/ja not_active Expired - Fee Related
- 1992-11-19 KR KR1019940701695A patent/KR100270133B1/ko not_active IP Right Cessation
- 1992-11-19 WO PCT/GB1992/002140 patent/WO1993010254A1/en active IP Right Grant
- 1992-11-19 DE DE69229402T patent/DE69229402T2/de not_active Expired - Fee Related
- 1992-11-19 NZ NZ245182A patent/NZ245182A/en unknown
- 1992-11-19 AT AT92923876T patent/ATE181114T1/de not_active IP Right Cessation
- 1992-11-19 US US08/244,263 patent/US5726055A/en not_active Expired - Fee Related
- 1992-11-19 DK DK92923876T patent/DK0615549T3/da active
- 1992-11-19 AU AU29494/92A patent/AU673145B2/en not_active Ceased
- 1992-11-19 PT PT101077A patent/PT101077B/pt not_active IP Right Cessation
- 1992-11-19 MX MX9206679A patent/MX9206679A/es not_active IP Right Cessation
- 1992-11-19 ZA ZA928937A patent/ZA928937B/xx unknown
- 1992-11-19 ES ES92923876T patent/ES2132135T3/es not_active Expired - Lifetime
- 1992-11-20 TW TW081109300A patent/TW240249B/zh active
-
1996
- 1996-09-20 AU AU65728/96A patent/AU6572896A/en not_active Abandoned
-
1998
- 1998-10-27 AU AU89540/98A patent/AU8954098A/en not_active Abandoned
- 1998-12-15 HK HK98113498A patent/HK1012423A1/xx not_active IP Right Cessation
-
1999
- 1999-08-18 GR GR990402107T patent/GR3031029T3/el unknown
-
2000
- 2000-02-23 KR KR1020000008723A patent/KR20070108290A/ko not_active Application Discontinuation
-
2001
- 2001-10-09 US US09/973,970 patent/US20020106762A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070108290A (ko) | 2007-11-09 |
| PT101077A (pt) | 1994-02-28 |
| US20020106762A1 (en) | 2002-08-08 |
| AU6572896A (en) | 1996-12-12 |
| EP0615549A1 (en) | 1994-09-21 |
| AU8954098A (en) | 1999-01-14 |
| PT101077B (pt) | 2000-09-29 |
| NZ245182A (en) | 1995-09-26 |
| TW240249B (el) | 1995-02-11 |
| JP3782099B2 (ja) | 2006-06-07 |
| US5726055A (en) | 1998-03-10 |
| ES2132135T3 (es) | 1999-08-16 |
| DE69229402T2 (de) | 1999-11-25 |
| JPH07503129A (ja) | 1995-04-06 |
| EP0615549B1 (en) | 1999-06-09 |
| AU673145B2 (en) | 1996-10-31 |
| EP0905255A3 (en) | 1999-04-14 |
| DK0615549T3 (da) | 1999-11-15 |
| MX9206679A (es) | 1993-05-01 |
| CA2123782A1 (en) | 1993-05-27 |
| HK1012423A1 (en) | 1999-07-30 |
| EP0905255A2 (en) | 1999-03-31 |
| DE69229402D1 (de) | 1999-07-15 |
| KR100270133B1 (ko) | 2000-10-16 |
| GB9124513D0 (en) | 1992-01-08 |
| ZA928937B (en) | 1994-03-17 |
| AU2949492A (en) | 1993-06-15 |
| ATE181114T1 (de) | 1999-06-15 |
| WO1993010254A1 (en) | 1993-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3031029T3 (en) | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase. | |
| HUT53368A (en) | Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them | |
| AU6128590A (en) | Novel compounds | |
| CA2017076A1 (en) | Alkoxyiminoacetamide derivatives and their use as fungicides | |
| AU535181B2 (en) | Alpha-azolyl gylcol derivatives | |
| AU1233188A (en) | Deuterated aryl aldehydes and derivatives thereof | |
| HU9203284D0 (en) | Method for producing thiazolidine-2,4-dione derivatives and medical preparatives containing these compounds | |
| KR880001677A (ko) | β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체 | |
| EP0270093A3 (en) | Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties | |
| FI911016A0 (fi) | Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi | |
| DE3267188D1 (en) | Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same | |
| IE820239L (en) | Carbapenem derivatives | |
| EP0555479A4 (el) | ||
| ATE125256T1 (de) | Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung. | |
| HU913293D0 (en) | Process for the production of pierazine derivatives and medical preparations containing them | |
| HU903953D0 (en) | Process for producing imidazole derivatives | |
| ATE109454T1 (de) | Catecholaminester. |